Patents by Inventor Preethy Paul

Preethy Paul has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240284918
    Abstract: The invention relates to insect repellent compositions, in particular to insect repellent compositions comprising hexahydrofarnesyl acetone (HFA), preferably HFA related substances, and a delivery vehicle. The invention also relates to the use of HFA as an insect repellent. Further objects of the invention are the use of oils and enriched extracts of Anisomeles species as insect repellents, and a method of repelling insects and for preventing diseases caused or transmitted by insects. The insect repellent compositions of the invention can provide a prolonged period of protection to a minimum of 8 hours.
    Type: Application
    Filed: May 20, 2022
    Publication date: August 29, 2024
    Inventors: Senthil Kumar Rajendran, Preethy Paul, John Eriksson, Patrik Eklund
  • Patent number: 10196371
    Abstract: A compound of Formula 1 wherein, X represents an alkyl, alkylene, alkenyl, alkenylene, alkynyl or alkynylene group, optionally having at least one substituent selected from the group of —OR1 and —NR1R2, or Y represents —OTBS, —OR1, —NR1R2; Z represents —OR3 or ?O; and R1, R2 and R3 each independently stand for H, alkyl, alkenyl, alkynyl, aryl, heteroaryl, or heterocyclyl, optionally in the form of enantiomers racemic mixtures, or pharmaceutically acceptable salts thereof, for use as a medicament, in particular for use in anti-viral cancer treatment in mammals and for use in treatment of benign or neoplastic genital Human Papilloma Virus associated diseases and for use in treatment of non-genital warts.
    Type: Grant
    Filed: August 17, 2015
    Date of Patent: February 5, 2019
    Assignee: Äbo Akademi
    Inventors: Senthil Kumar Rajendran, Preethy Paul, Yury Brusentsev, Fang Cheng, Patrik Eklund, John Elias Eriksson
  • Publication number: 20170275263
    Abstract: A compound of Formula 1 wherein, X represents an alkyl, alkylene, alkenyl, alkenylene, alkynyl or alkynylene group, optionally having at least one substituent selected from the group of —OR1 and —NR1R2, or Y represents —OTBS, —OR1, —NR1R2; Z represents —OR3 or ?O; and R1, R2 and R3 each independently stand for H, alkyl, alkenyl, alkynyl, aryl, heteroaryl, or heterocyclyl, optionally in the form of enantiomers racemic mixtures, or pharmaceutically acceptable salts thereof, for use as a medicament, in particular for use in anti-viral cancer treatment in mammals and for use in treatment of benign or neoplastic genital Human Papilloma Virus associated diseases and for use in treatment of non-genital warts.
    Type: Application
    Filed: August 17, 2015
    Publication date: September 28, 2017
    Inventors: Senthil Kumar Rajendran, Preethy Paul, Yury Brusentsev, Fang Cheng, Patrik Eklund, John Elias Eriksson
  • Patent number: 9623002
    Abstract: A pharmaceutical composition for anti-viral cancer treatment in mammals, comprising a therapeutically effective amount of Anisomelic acid or salts thereof. The pharmaceutical composition may comprise Anisomelic acid or salt thereof in an oil-in-water emulsion, for example in an isotropic mixture of at least one oil and at least one surfactant or, alternatively, in a hydrophilic solvent and a co-solvents or surfactant or a combination thereof. A method of treating or preventing of cancer in a mammal, wherein the p53 pathway is deregulated by viral oncoproteins, is also provided.
    Type: Grant
    Filed: August 17, 2015
    Date of Patent: April 18, 2017
    Inventors: John E. Eriksson, Preethy Paul, Emilia Peuhu, M. A. Akbarsha
  • Patent number: 9345687
    Abstract: A pharmaceutical composition for anti-viral cancer treatment in mammals, comprising a therapeutically effective amount of Anisomelic acid or salts thereof. The pharmaceutical composition may comprise Anisomelic acid or salt thereof in an oil-in-water emulsion, for example in an isotropic mixture of at least one oil and at least one surfactant or, alternatively, in a hydrophilic solvent and a co-solvents or surfactant or a combination thereof. A method of treating or preventing of cancer in a mammal, wherein the p53 pathway is deregulated by viral oncoproteins, is also provided.
    Type: Grant
    Filed: August 28, 2013
    Date of Patent: May 24, 2016
    Inventors: John E. Eriksson, Preethy Paul, Emilia Peuhu, M. A. Akbarsha
  • Publication number: 20160136126
    Abstract: A pharmaceutical composition for anti-viral cancer treatment in mammals, comprising a therapeutically effective amount of Anisomelic acid or salts thereof. The pharmaceutical composition may comprise Anisomelic acid or salt thereof in an oil-in-water emulsion, for example in an isotropic mixture of at least one oil and at least one surfactant or, alternatively, in a hydrophilic solvent and a co-solvents or surfactant or a combination thereof. A method of treating or preventing of cancer in a mammal, wherein the p53 pathway is deregulated by viral oncoproteins, is also provided.
    Type: Application
    Filed: August 17, 2015
    Publication date: May 19, 2016
    Inventors: John E. Eriksson, Preethy Paul, Emilia Peuhu, M.A. Akbarsha